While the exact role of serine methyltransferases in ER+ breast cancer remains unknown, a number of recent studies have begun to demonstrate a significant role for one carbon metabolism and SHMT2, which is transcriptionally activated by ERRα [133,135]. This evidence concerns the gene SHMT2 and breast carcinoma.